Skip to main content
OpenTrials
Completed

NCT Number: NCT02794454

A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health

Sexual function is a part of a normal healthy life and considered to be essential for mental, physical and marital well-being. Any derangement in normal function though is a distressing situation for the individual, is often not reported due to embarrassment or due to social stigma. Sexual disorders in men are categorized according to the stage of sexual response affected in terms of disorders of erectile function, ejaculatory function or libido, albeit there is considerable potential for overlap amongst the disorders. The use of current intervention has many side-effects and has been prohibited in cardiovascular condition and also to be taken with caution with other medical condition.

This has led to the development of multiple alternate therapies which are helpful for a limited number of cases but the major concern for all these therapies is their late onset of action and not having a sustained effect.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Erectile Dysfunction Ejaculatory Dysfunction Genital Diseases Genital Diseases, Male Male Urogenital Diseases Mental Disorders Premature Ejaculation Sexual Dysfunction, Physiological Sexual Dysfunctions, Psychological Urogenital Diseases

Age range

30 year–60 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

About this study

Enovate Biolife is trying to improvise further their already marketed product HeezOn® by adding new botanicals thus naming it HeezOn Ultra. HeezOn®has been studied on 148 subjects and has proven to be beneficial for subjects with mild to moderate ED. The previous study fell short to capture the data for subjects who were also suffering from PE and their overall quality of life-related to sexual health. Therefore, the trial is designed to study the speedy and sustained effect of the improvised formula on different aspects of sexual dysfunctions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Planning to have regular sexual activity (more than twice/ week).
  • Body Mass Index should be ≤ 29 kg/m2.
  • Subjects suffering from erectile dysfunction indicated by SHIMscore ≥ 12 and ≤ 16 for more than 3 months and less than 6 months.

OR

  • Subjects suffering from predominantly from premature ejaculation as indicated by PEDT score more than 11 for more than 3 months and less than 6 months.
  • Fasting blood sugar ≤ 120 mg/dl.
  • The subjects have to be non-smoker and non-alcoholic.

Exclusion criteria

  • Subjects having SHIM score <12 and > 16.
  • Subjects suffering from premature ejaculation predominantly as indicated by PEDT score less than 11.
  • Subjects with major psychiatric disorders or severe systemic disorders
  • Subject having uncontrolled diabetes mellitus and hypertensive on active treatment
  • Subjects having history of male sexual dysfunction more than six months in diabetic subjects.
  • Anatomical deformity of the penis such as severe penile fibrosis or Peyronie's disease or phimosis.
  • Subjects detected with HIV and suffering from AIDS.
  • Has an abnormal thyroid stimulating hormone (TSH) level lower than 30% of lower limit normal or more than 30% of upper limit normal.
  • Has erectile dysfunction caused by neurological or endocrine factors such as hyper-prolactinemia.
  • Subjects with history of major systemic disorders.
  • Subject with history of drug abuse.
  • Subjects using medications known to cause sexual dysfunction (cimetidine, spironolactone, thiazides, adrenergic blockers, antidepressants etc.)
  • Subject has participated in any clinical trial within last 30 days.
  • Subjects not ready to sign the consent & unable to comply the protocol.

Treatment and study plan

HeezOn Ultra-1

Other

HeezOn Ultra-2

Other

Placebo

Other

Primary outcomes

  1. Change in scores of Sexual Health Inventory for Men

    Time frame: Day 0, Day 1, Day 3, Day 14 and Day 28

Secondary outcomes

  1. Sexual Hormone Binding Globulin

    Time frame: Day 0 and Day 14

  2. Free Testosterone

    Time frame: Day 0 and Day 14

  3. Change in scores of Sexual Quality of Life - Male

    Time frame: Day 0, Day 1, Day 3, Day 14 and Day 28

Sponsors and collaborators

Lead sponsor

Vedic Lifesciences Pvt. Ltd.

Industry

Collaborators

  • Enovate Biolife Pvt Ltd

Registry information

Official study title

A Randomized, Placebo-controlled, Double-blind Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health

Acronym: HeezOn-Ultra

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jun 9, 2016
Registry last updated
Jan 30, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.